Hypercortisolemia in acute stroke is related to the inflammatory response.
Hypercortisolemia is thought to be a marker of the stress response following stroke. The aim of this study was to investigate the prevalence and prognostic significance of hypercortisolemia. The circadian variation of cortisol level and the relationship between serum cortisol levels and other stress, inflammatory, and haemostatic markers were also investigated. Seventy consecutive patients with their first ischemic stroke and 24 age- and sex-matched controls were included in the study. Serum cortisol levels (at 6:00 AM, 10:00 AM, 6:00 PM, and 10:00 PM), 24-h urine catecholamine excretion, beta-thromboglobulin levels, and other standard biochemical and haematological parameters were measured on the first day of hospitalisation and in control subjects. Outcome measures used the Barthel Index at Day 30, as well as 30- and 90-day mortality rates. Hypercortisolemia, defined as at least two of the four measurements above the normal range of serum cortisol levels (i.e. >618 nmol/l from the morning samples and >460 nmol/l from the evening samples) was found in 25 (35.7%) of the acute stroke patients and in 3 (12.5%) of the controls (p<0.05). Hypercortisolemia was associated with older age, greater severity of neurological deficit, larger ischemic lesions on CT, and worse prognoses (p<0.05). The study did not find a correlation between serum cortisol levels and other markers of the stress response such as catecholamines excretion and glucose levels. A significant correlation between serum cortisol levels and some markers of the inflammatory response, such as fever, fibrinogen level, white blood cell (WBC) count, and beta-thromboglobulin level, was established in stroke patients. Prognostic significance of hypercortisolemia in acute stroke patients seems to be related to the inflammatory response rather than to the stress response.
Slowik
Agnieszka
A
Stroke Unit, Department of Neurology, Collegium Medicum, Jagiellonian University, Botaniczna 3 31-503, Krakow, Poland. slowik@neuro.cm-uj.krakow.pl
Turaj
Wojciech
W
Pankiewicz
Joanna
J
Dziedzic
Tomasz
T
Szermer
Paweł
P
Szczudlik
Andrzej
A
D000208:Acute Disease; D000308:Adrenocortical Hyperfunction / Q000097:blood* / Q000276:immunology / Q000503:physiopathology; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002940:Circadian Rhythm / Q000276:immunology; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood* / Q000276:immunology; D007249:Inflammation / Q000097:blood / Q000276:immunology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D015995:Prevalence; D011379:Prognosis; D012737:Sex Factors; D013312:Stress, Physiological / Q000097:blood* / Q000276:immunology / Q000503:physiopathology; D020521:Stroke / Q000097:blood* / Q000276:immunology / Q000503:physiopathology; D015996:Survival Rate; D015854:Up-Regulation / Q000276:immunology*
D006854:Hydrocortisone